We are happy to announce that Thomas Reiberger, Associate Professor at the Division of Gastroenterology and Hepatology at the Medical University of Vienna, and Adjunct Principal Investigator at LBI-RUD and CeMM, will be opening a new Christian Doppler laboratory for portal hypertension and fibrosis in liver diseases at the Medical University of Vienna.

In a public-private partnership between the Christian Doppler Research Association (CDG), the Medical University of Vienna, Boehringer Ingelheim, and the Federal Ministry for Digital and Economic Affairs, the new CD lab aims at developing treatment options for portal vein hypertension and fibrosis in liver diseases. The CD lab is based on fundamental research and will focus particularly on the identification of molecular mechanisms that contribute to fibrogenesis and the pathological changes in the blood supply to the liver.

When: Monday, 15 June 2020 | 14:00 – 15:15

The online event will be held in German and moderated by Michael Trauner, Head of the Clinical Department for Gastroenterology and Hepatology, MedUni Vienna.

Register and access the event via this link.

Full programme:

Welcome address by:

  • Michaela Fritz (Vice Rector for Research and Innovation, MedUni Vienna)
  • Martin Gerzabek (President of the Christian Doppler Research Association)

Introduction to the research topic as a molecular-medical interface at the MedUni Vienna

  • Philipp Schwabl (Clinical Department for Gastroenterology and Hepatology, MedUni Vienna)
  • Giulio Superti-Furga (CeMM Scientific Director and CEO)

Presentation of the CD laboratory for portal hypertension and fibrosis in liver diseases

  • Thomas Reiberger (Head of CD Laboratory, Assoc. Prof. Division of Gastroenterology and Hepatology at MedUni Vienna)
  • Rüdiger Streicher (Boehringer Ingelheim)
No news available.